Condition
Juvenile Idiopathic Scoliosis
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Terminated2
Active Not Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07527611Completed
Development of a Conservative Care and Bracing Registry (CCBR)
NCT04929678Not ApplicableTerminatedPrimary
Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis
NCT06733623Active Not Recruiting
Impact of Spinal Curves on Asymmetric Posture in Idiopathic Scoliosis
NCT05730920Phase 4Completed
IV Methadone Vs EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Idiopathic Scoliosis Correction
NCT04992845Not ApplicableTerminated
Fusionless Treatment of Idiopathic Scoliosis With the SCOLI-TETHER System During The Growth Period
Showing all 5 trials